Insider trading

Period: 120 months Stock: OFIX Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

45 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

45 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

45 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

45 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
45 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
45 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

45 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
1 Oct 2026
Fisher Patrick President, Global Limb Recon
Sold on a plan
$1.42K 150 at 9.44
0.3%
Planned (10b5-1)
1 Sep 2026
Fisher Patrick President, Global Limb Recon
Sold on a plan
$1.41K 150 at 9.39
0.3%
Planned (10b5-1)
18 Aug 2026
Fisher Patrick President, Global Limb Recon
Sold at will
$13.07K 1,295 at 10.09
2.5%
Not planned
18 Jun 2026
McPherron Aviva Pres, Global Ops & Qual
Sold at will
$34.42K 3,670 at 9.38
5.2%
Not planned
16 Apr 2026
Sold at will
$47.99K 3,743 at 12.82
6.0%
Not planned
17 Mar 2026
Vitale Lucas CP&BOO
Sold at will
$50.89K 4,269 at 11.92
2.6%
Not planned
5 Mar 2026
Sold at will
$17.19K 1,370 at 12.55
2.1%
Not planned
5 Mar 2026
McPherron Aviva Pres, Global Ops & Qual
Sold at will
$15.85K 1,263 at 12.55
1.8%
Not planned
5 Mar 2026
Vitale Lucas CP&BOO
Sold at will
$14.32K 1,141 at 12.55
0.7%
Not planned
5 Mar 2026
REINHARDT MAX President, Global Spine
Sold at will
$13.22K 1,053 at 12.55
4.0%
Not planned
5 Mar 2026
Fisher Patrick President, Global Limb Recon
Sold at will
$9.51K 758 at 12.55
1.5%
Not planned
4 Mar 2026
Sold at will
$18.15K 1,405 at 12.92
2.1%
Not planned
4 Mar 2026
McPherron Aviva Pres, Global Ops & Qual
Sold at will
$16.74K 1,296 at 12.92
1.8%
Not planned
4 Mar 2026
Vitale Lucas CP&BOO
Sold at will
$15.12K 1,171 at 12.92
0.7%
Not planned
4 Mar 2026
REINHARDT MAX President, Global Spine
Sold at will
$13.95K 1,080 at 12.92
3.9%
Not planned
4 Mar 2026
Fisher Patrick President, Global Limb Recon
Sold at will
$10.05K 778 at 12.92
1.5%
Not planned
18 Aug 2025
Fisher Patrick President, Global Orthopedics
Sold at will
$28.36K 1,996 at 14.21
6.2%
Not planned
18 Jun 2025
McPherron Aviva Pres, Global Ops & Qual
Sold at will
$39.18K 3,728 at 10.51
7.4%
Not planned
11 Jun 2025
REINHARDT MAX President, Global Spine
Sold at will
$19.12K 1,643 at 11.64
5.6%
Not planned
16 Apr 2025
Sold at will
$50.79K 3,816 at 13.31
8.2%
Not planned
2 Apr 2025
Sold at will
$1.20K 76 at 15.74
0.2%
Not planned
18 Mar 2025
Vitale Lucas CP&BOO
Sold at will
$71.16K 4,287 at 16.60
3.1%
Not planned
18 Mar 2025
Sold at will
$4.91K 296 at 16.60
0.7%
Not planned
4 Feb 2025
Sold at will
$3.38K 187 at 18.08
0.5%
Not planned
3 Feb 2025
Sold at will
$13.64K 767 at 17.79
1.9%
Not planned
13 Jan 2025
Sold at will
$3.89K 227 at 17.14
0.6%
Not planned
10 Jan 2025
Sold at will
$4.17K 248 at 16.83
0.6%
Not planned
8 Jan 2025
Sold at will
$4.04K 238 at 16.97
0.6%
Not planned
7 Jan 2025
Sold at will
$4.08K 238 at 17.14
0.6%
Not planned
17 Dec 2024
Sold at will
$463.84 26 at 17.84
0.1%
Not planned
26 May 2023
Kenny Kevin J. President of Global Spine
Sold at will
$73.64K 3,876 at 19.00
2.6%
Not planned
24 May 2023
Kenny Kevin J. President of Global Spine
Sold at will
$82.97K 4,367 at 19.00
2.9%
Not planned
18 Nov 2021
Elting Kimberley A. Chief Legal & Develop. Officer
Bought
$30.34K 1,000 at 30.34
2.2%
First buy on file
5 Jun 2020
Finegan Michael Chief Strategy Officer
Sold, plan not stated
$327.32K 8,750 at 37.41
15.4%
19 Feb 2019
Bianchi Davide President, Global Extremities
Sold, plan not stated
$1.57M 24,199 at 65.00
53.9%
Sold half or more
15 Feb 2019
Bianchi Davide President, Global Extremities
Sold, plan not stated
$13.07K 201 at 65.00
0.4%
5 Nov 2018
NIEMANN BRADLEY V. President of Global Spine
Sold, plan not stated
$23.85K 387 at 61.63
1.5%
2 Nov 2018
Elting Kimberley A. Chief Legal & Admin Officer
Sold, plan not stated
$427.34K 7,000 at 61.05
30.8%
3 Jul 2018
NIEMANN BRADLEY V. President of Global Spine
Sold, plan not stated 2×
$641.44K 11,250 at 57.02
29.4%
20 Jun 2018
FUJIKAWA RAYMOND President Spine Fixation
Sold, plan not stated 2×
$1.94M 32,243 at 60.21
71.5%
Sold half or more
19 Jun 2018
Bianchi Davide President Extremity Fixation
Sold, plan not stated
$885.72K 14,762 at 60.00
26.4%
18 Jun 2018
Finegan Michael Chief Strategy Officer
Sold, plan not stated 2×
$1.76M 30,000 at 58.81
44.9%
11 Dec 2017
NIEMANN BRADLEY V. President Biostim
Sold, plan not stated
$288.86K 5,547 at 52.08
13.8%
11 Sep 2017
NIEMANN BRADLEY V. President Biostim
Sold, plan not stated
$343.93K 6,956 at 49.44
14.8%
10 Aug 2017
FUJIKAWA RAYMOND President Spine Fixation
Sold, plan not stated
$299.50K 6,364 at 47.06
17.0%
Showing 1–45 of 45.